Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Circulation|January 31, 2016
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective RegistryMarion Delcroix, Irene Lang, Joanna Pepke-Zaba, et al.
The European Respiratory Journal|December 18, 2020
ERS statement on chronic thromboembolic pulmonary hypertensionMarion Delcroix, Adam Torbicki, Deepa Gopalan, et al.
Polskie Archiwum Medycyny Wewnetrznej|February 7, 2013
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]Krystyna Zawilska, Małgorzata M Bała, Piotr Błędowski, et al.
Orphanet Journal of Rare Diseases|February 25, 2026
The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test - results of multicenter national registry (BNP-PL)Michał Piłka, Szymon Darocha, Marcin Waligóra, et al.
Journal of Clinical Medicine|January 16, 2020
Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)Grzegorz Kopeć, Marcin Kurzyna, Ewa Mroczek, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2021
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registrySzymon Darocha, Marek Roik, Grzegorz Kopeć, et al.
Human Mutation|January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado, Micheala A Aldred, Victoria James, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
The New England Journal of Medicine|April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolismGuy Meyer, Eric Vicaut, Thierry Danays, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Pageof 19